The possible explanations were (1) EGFL7 could regulate several pathways (including EGF receptor (EGFR)/protein kinase B (AKT) signaling) to promote cell proliferation, thereby accelerated MM progression [18]. Here, AKT1 is linked to Miyoshi myopathy.